Ventyx Biosciences
VTYX
VTYX was delisted on the 3rd of March, 2026.
124 hedge funds and large institutions have $119M invested in Ventyx Biosciences in 2024 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 45 increasing their positions, 27 reducing their positions, and 20 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 27
40% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 20
5% more funds holding
Funds holding: 118 → 124 (+6)
2.74% more ownership
Funds ownership: 74.26% → 77% (+2.7%)
4% more capital invested
Capital invested by funds: $114M → $119M (+$4.83M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
43% less call options, than puts
Call options by funds: $232K | Put options by funds: $408K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$7.65M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$5.86M |
| 3 |
Morgan Stanley
New York
|
+$4.94M |
| 4 |
SCM
Sio Capital Management
New York
|
+$4.7M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$14M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$6.91M |
| 3 |
OCA
Octagon Capital Advisors
New York
|
-$5.21M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$4.49M |
| 5 |
Goldman Sachs
New York
|
-$961K |
VTYX Hedge Fund Activity: Q4 2024 in Review
124 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q4 2024, worth a combined $119M — up 4.2% from $114M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new VTYX positions and 20 closed out — a net gain of 8 holders — while 45 added to existing stakes and 27 trimmed.
The largest buyer was Bank of America, adding an estimated $7.65M. The largest seller was Deerfield Management, cutting an estimated $14M.
- 124 institutional investors held Ventyx Biosciences (VTYX) as of Q4 2024, up from 118 in Q3 2024.
- Funds reported $119M of Ventyx Biosciences stock for Q4 2024, up 4.2% quarter-over-quarter.
- 28 funds opened new Ventyx Biosciences positions in Q4 2024 and 20 closed out, a net change of +8 holders.
- The largest Ventyx Biosciences buyer in Q4 2024 was Bank of America, an estimated $7.65M added.
- The largest Ventyx Biosciences seller in Q4 2024 was Deerfield Management, an estimated $14M sold.
Based on aggregated 13F filings for Q4 2024.